Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Drive Medical - DeVilbiss Healthcare

DeVilbiss Healthcare is a world leader in the design, manufacture, and marketing of respiratory medical products, inc... read more Featured Products: More products

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Worldwide Growth Seen in Respiratory Device Market

By HospiMedica International staff writers
Posted on 07 Apr 2014
The global respiratory device market continues to grow, mainly due to the aging of the world population and increasing incidence of respiratory diseases. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

The bulk of revenue of the USD 47 billion-dollar market, which includes inhalers, oxygen systems, oximeters, and other equipment, is derived from the 36 billion inhaler segment. The segment comprises metered dose inhalers or dry powder versions, which are commonly used for the treatment of asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), or any lung disease characterized by chronic or acute inflammation. They consist of a micronized form of drug in a propellant under pressure with surfactants to prevent clumping of drug crystals.

Other products such as endotracheal tubes, tracheostomy tubes, nasopharyngeal catheters, and oxygen mask devices, which comprise a smaller portion of the market, will see faster growth, since many are disposable and used in hospital or homecare settings. Material innovations are also driving a rising demand in products focusing on comfort and wearability, such as the Devilbiss (Somerset, PA, USA) EasyFit SilkGel Nasal and Full Face Mask, and the Teleflex Softech Plus nasal cannula. The market encompasses many different products to help treat and monitor respiratory conditions, as well as many large and small manufacturers.

“The market for inhalers continues to grow based on the aging of the world population, an increase in respiratory diseases and a general increase in conditions,” said report author Kalorama analyst Mary Anne Crandall. “Because of the ease of use and advancements in inhaler delivery, drug companies and drug delivery manufacturers are increasing interest in this technology.”

According to the report, the device market will grow at a 4.6% compound annual growth rate (CAGR), reaching 59 billion in 2018; revenue growth in the high-demand comfort and wearability products is predicted to be 50% faster than the overall market.

Related Links:

Kalorama Information
Devilbiss



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.